Where is insulin metabolised

Create a personalised content profile. Measure ad performance. Select basic ads. Create a personalised ads profile. Select personalised ads. Apply market research to generate audience insights. Measure content performance. Develop and improve products. List of Partners vendors. Insulin is a hormone produced by the pancreas to help metabolize food and use it for energy throughout your body.

This is a key biological function. A problem with insulin can have widespread effects on any or all of your tissues, organs, and systems. Insulin is critical to your overall health and survival. Problems with insulin production or function can result in hypoglycemia low blood sugars , hyperglycemia high blood sugars , and diabetes. If you have any type of diabetes, learning how insulin works in the body can help clarify why taking daily insulin shots or wearing an insulin pump or patch may be a key aspect of your treatment plan.

This article discusses the relationship between insulin, blood sugar glucose , and diabetes. It also covers how your body makes insulin and ways your health can be affected if you have too little or too much of it in your bloodstream. Insulin is produced by the pancreas, a gland-like organ nestled in the curve of the duodenum the first part of the small intestine , just behind the stomach.

The pancreas functions both as an exocrine gland and an endocrine gland. The exocrine function of the pancreas is to help with digestion. The endocrine function of the pancreas is to produce insulin and another hormone called glucagon that helps regulate blood sugar. The pancreatic cells that produce glucagon are called alpha cells. Insulin is produced by specialized beta cells in the pancreas, which are clustered into groups called islets of Langerhans , or islets for short.

Insulin is the energy-storage hormone. After a meal, it helps the cells use carbs, fats, and protein as needed, and store what's left mainly as fat for the future. The body breaks these nutrients down into sugar molecules, amino acid molecules, and lipid molecules, respectively. The body also stores and reassembles these molecules into more complex forms.

Blood sugar levels rise when most foods are consumed, but they rise more rapidly and dramatically with carbohydrates. The digestive system releases glucose from foods and the glucose molecules are absorbed into the bloodstream.

The rising glucose levels signal the pancreas to secrete insulin to clear glucose from the bloodstream. To do this, insulin binds with insulin receptors on the surface of cells, acting like a key that opens the cells to receive glucose.

Insulin receptors exist on almost all tissues in the body, including muscle cells and fat cells. Insulin receptors have two main components:. When the body is functioning normally, the glucose derived from ingested carbohydrates gets cleared rapidly through this process.

However, when there's no insulin or very low levels of insulin, this doesn't happen, leading to high blood glucose levels.

Excess blood sugar also happens when cells aren't able to use insulin properly—what's known as insulin resistance. This can be caused by a problem with the shape of the insulin preventing receptor binding , not having enough insulin receptors, signaling problems, or glucose transporters not working properly. Insulin resistance can also occur as a result of excess body fat.

Insulin has a major effect on fat metabolism. After a meal, insulin causes "extra" ingested fats and glucose to be stored as fat for future use. Insulin also plays a key role in liver function and fat cells. Liver Function. Insulin stimulates the glycogen creation from glucose and its storage in the liver. High insulin levels cause the liver to get saturated with glycogen. When this happens, the liver becomes unable to store more.

Then, glucose is instead used to create fatty acids that are converted into lipoproteins and released into the bloodstream. These break down into free fatty acids and are used in other tissues. Some tissues use these to create triglycerides.

Fat Cells. Adipose tissue dysfunction and altered systemic amino acid metabolism are associated with non-alcoholic fatty liver disease. Iwasa, M. Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment. Bhattacharya, S. Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization.

Atherosclerosis , — Shah, S. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Newgard, C. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Wurtz, P. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36 , — Metabolomics and metabolic diseases: where do we stand? This comprehensive review discusses the emerging roles of metabolites, especially BCAAs, in insulin resistance.

Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease. Interplay between lipids and branched-chain amino acids in development of insulin resistance.

She, P. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Wang, T. Metabolite profiles and the risk of developing diabetes.

Lackey, D. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Herman, M. Burrill, J. Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes. Zimmerman, H. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.

Shin, A. Lefort, N. Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle. White, P. Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export.

Pedersen, H. Human gut microbes impact host serum metabolome and insulin sensitivity. Lotta, L. Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a Mendelian randomisation analysis. Smith, G. Protein ingestion induces muscle insulin resistance independent of leucine-mediated mTOR activation. Macotela, Y. Dietary leucine — an environmental modifier of insulin resistance acting on multiple levels of metabolism.

Zeanandin, G. Differential effect of long-term leucine supplementation on skeletal muscle and adipose tissue in old rats: an insulin signaling pathway approach. Age Dordr 34 , — Xiao, F. Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucose metabolism in mice.

Metabolism 63 , — Jang, C. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Roberts, L. Sun, H. Catabolic defect of branched-chain amino acids promotes heart failure.

Circulation , — Li, T. Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Green, C. Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis. Su, X. Adipose tissue monomethyl branched-chain fatty acids and insulin sensitivity: effects of obesity and weight loss. Obesity Silver Spring 23 , — Malloy, V. Methionine restriction decreases visceral fat mass and preserves insulin action in aging male Fischer rats independent of energy restriction.

Aging Cell 5 , — Stone, K. Mechanisms of increased in vivo insulin sensitivity by dietary methionine restriction in mice. Diabetes 63 , — Wanders, D. UCP1 is an essential mediator of the effects of methionine restriction on energy balance but not insulin sensitivity. FGF21 mediates the thermogenic and insulin-sensitizing effects of dietary methionine restriction but not its effects on hepatic lipid metabolism. Epner, D. Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction.

Cancer 42 , — Mentch, S. Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism. Chen, T. Tryptophan predicts the risk for future type 2 diabetes. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Laferrere, B. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss.

Transl Med. Cotter, D. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. Puchalska, P. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Taggart, A. Kimura, I. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 GPR Shimazu, T.

Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Goldberg, E. Youm, Y. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Rheinheimer, J. Metabolism 74 , 1—9 Houstis, N. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Fisher, F. Understanding the physiology of FGF Foster, G. A randomized trial of a low-carbohydrate diet for obesity. Chavez, A. Circulating fibroblast growth factor is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

Diabetes Care 32 , — Fazeli, P. FGF21 and the late adaptive response to starvation in humans. Douris, N. Beta-adrenergic receptors are critical for weight loss but not for other metabolic adaptations to the consumption of a ketogenic diet in male mice. Chavez-Talavera, O.

Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology , — Preidis, G. Kawamata, Y. A G protein-coupled receptor responsive to bile acids. Maruyama, T.

Identification of membrane-type receptor for bile acids M-BAR. Broeders, E. The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Watanabe, M. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

Somm, E. JCI Insight 2 , Fujisaka, S. Antibiotic effects on gut microbiota and metabolism are host dependent. Kumar, D. Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet alpha cells to promote glucose homeostasis. Thomas, C. TGR5-mediated bile acid sensing controls glucose homeostasis. Ding, L. Weber, G. Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin. Enzyme Regul. Pelley, J. Deng, Y. An adipo-biliary-uridine axis that regulates energy homeostasis.

Science , eaaf Yamamoto, T. Relationship between plasma uridine and insulin resistance in patients with non-insulin-dependent diabetes mellitus. Nucleosides Nucleotides Nucleic Acids 29 , — Hamada, T. Plasma levels of uridine correlate with blood pressure and indicators of myogenic purine degradation and insulin resistance in hypertensive patients.

Urasaki, Y. Chronic uridine administration induces fatty liver and pre-diabetic conditions in mice. Krylova, I. Effect of uridine on energy metabolism, LPO, and antioxidant system in the myocardium under conditions of acute coronary insufficiency. Le, T. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation. Hall, A. Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.

Agarwal, A. Schweitzer, G. Liver-specific loss of lipinmediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice. Chibalin, A. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Zhang, C. Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol. Jornayvaz, F.

Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. Monetti, M. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Choi, C. Suppression of diacylglycerol acyltransferase-2 DGAT2 , but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. Aburasayn, H. Targeting ceramide metabolism in obesity. Fayyaz, S. Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype.

Diabetologia 57 , — Hu, W. Palmitate increases sphingosinephosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity. Kaiser, C. Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation. BMC Biol. Cao, J. Endotoxemia-mediated activation of acetyltransferase P impairs insulin signaling in obesity.

LaBarge, S. Is acetylation a metabolic rheostat that regulates skeletal muscle insulin action? Cells 38 , — Zhao, S. Regulation of cellular metabolism by protein lysine acetylation. Sundaresan, N. Signal 4 , ra46 Glidden, E. Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 mTORC2 -dependent phosphorylation of Akt protein.

Yu, J. Boutant, M. SIRT1 metabolic actions: integrating recent advances from mouse models. Download references. The authors thank A. Santoro for comments on the manuscript. You can also search for this author in PubMed Google Scholar.

Correspondence to Qin Yang or Barbara B. The other authors declare no competing interests. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. A family of pattern-recognition receptors with a role in innate immunity.

For example, TLR4 is activated upon dimerization with the co-receptor myeloid differentiation protein 2 MD2 ; signalling via TLR4—MD2 results in the transcription of pro-inflammatory genes. A novel epidemiological study design that uses genetic variants to investigate the causal relationship of a biomarker to the risk of having a phenotype or disease.

Two molecules that have the same molecular formula but differ in the orientation of atoms. The sn position is often used to define the configuration of glycerol-containing metabolites. When the OH group on the second carbon sn-2 of glycerol is oriented to the left, the top first carbon is at the sn-1 position and the bottom third carbon is at the sn-3 position.

Hepatitis caused by excessive fat deposition in the liver that is not related to heavy alcohol use. Cycles to remodel phospholipids by first de-acylating and then re-acylating them, thereby altering the fatty acid moiety to generate mature phospholipids.

Pathways that replenish tricarboxylic acid cycle intermediates, which can then be used for energy production or for gluconeogenesis in the liver. A subset of entero-endocrine cells that secrete gut peptides such as glucagon-like peptide 1 GLP1 , incretins, etc.

Reprints and Permissions. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol 19, — Download citation. Published : 13 August Issue Date : October Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative. Lipids in Health and Disease Scientific Reports Translational Psychiatry Advanced search.

Skip to main content Thank you for visiting nature. Abstract The cause of insulin resistance in obesity and type 2 diabetes mellitus T2DM is not limited to impaired insulin signalling but also involves the complex interplay of multiple metabolic pathways. Access through your institution. Buy or subscribe. Rent or Buy article Get time limited or full article access on ReadCube. References 1. CAS Google Scholar 2. CAS Google Scholar 3.

CAS Google Scholar 4. CAS Google Scholar 6. CAS Google Scholar 7. CAS Google Scholar 8. CAS Google Scholar PubMed Google Scholar Google Scholar Acknowledgements The authors thank A. Kahn Authors Qin Yang View author publications. View author publications. Ethics declarations Competing interests B. Supplementary information. Supplementary Boxes 1—3.

Glossary Toll-like receptors TLRs. Mendelian randomization A novel epidemiological study design that uses genetic variants to investigate the causal relationship of a biomarker to the risk of having a phenotype or disease.

Stereoisomers Two molecules that have the same molecular formula but differ in the orientation of atoms. Stereospecific numbering sn. Non-alcoholic steatohepatitis NASH. Lands cycle Cycles to remodel phospholipids by first de-acylating and then re-acylating them, thereby altering the fatty acid moiety to generate mature phospholipids. Anaplerotic pathways Pathways that replenish tricarboxylic acid cycle intermediates, which can then be used for energy production or for gluconeogenesis in the liver.

Periportal neural system The nervous system that innervates the liver. L cells A subset of entero-endocrine cells that secrete gut peptides such as glucagon-like peptide 1 GLP1 , incretins, etc. Rights and permissions Reprints and Permissions.

About this article. Cite this article Yang, Q. Copy to clipboard. Whelchel , Sarah E. Any role for reduced brain glucose metabolism?

Search Search articles by subject, keyword or author. Show results from All journals This journal. At a cellular level in most tissues, insulin degradation is initiated by the hormone binding to specific receptors. The hormone-receptor complex is processed, including internalization and degradation of at least some of the hormone-receptor complexes.

The enzyme or enzymes involved in the degradative process have not been established, but three systems have been implicated: insulin protease, glutathione insulin transhydrogenase GIT , and lysosomal enzymes. Most users should sign in with their email address. If you originally registered with a username please use that to sign in.

To purchase short term access, please sign in to your Oxford Academic account above. Don't already have an Oxford Academic account? Oxford University Press is a department of the University of Oxford.

It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation.

Volume 2. Insulin Metabolism and Degradation. Duckworth , William C.